1. Alzheimer’s disease drug development and the problem of the blood-brain barrier;Pardridge;Alzheimers Dement,2009
2. Amyloid β-protein oligomers and Alzheimer’s disease;Hayden;Alzheimers Res Ther,2013
3. Bourdenx M , Koulakiotis NS , Sanoudou D , Bezard E , Dehay B , Tsarbopoulos A (2015) Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies, and synucleinopathies. Prog Neurobiol. doi: 10.1016/jpneurobio.2015.07.003
4. Amyloid-β oligomers relate to cognitive decline in Alzheimer’s disease;Jongbloed;J Alzheimers Dis,2015
5. Mitochondrial biology in Alzheimer’s disease pathogenesis;Galindo;J Neurochem,2010